Sarcoma, Soft tissue sarcoma
Results
Phase 2
This trial looked at cabozantinib for people with GIST that had continued to grow despite treatment.
The trial was open for people to join between 2017 and 2018. The team published the results in 2020.
Recruitment start: 28 February 2017
Recruitment end: 31 August 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Patrick Schöffski
European Organisation for Research and Treatment of Cancer (EORTC)
Exelixis Inc
There is more information about this trial on the clinicaltrials.gov website (NCT02216578):
The research team would like to thank all the patients who took part in this trial. By doing this, you’ve helped the research team learn more about cancer and how to treat it.
Last reviewed: 07 Mar 2023
CRUK internal database number: 18521
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
